ProCE Banner Activity

Long-term, Real-world Safety and Efficacy of LA ART: Perspectives From Europe

Conference Coverage
Clinical Thought

At CROI 2025, data from the CARES trial and the OPERA cohort demonstrated the long-term, real-world safety and efficacy of LA ART. Read on to learn how these results could shift the paradigm of HIV care in Europe and globally.

Released: April 02, 2025

Expiration: April 01, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Faculty Disclosure

Primary Author

Marta Boffito, MD, PhD, FRCP, MBA: consultant/advisor/speaker: AstraZeneca, Gilead, GlaxoSmithKline, Merck Sharp & Dohme, Pfizer, ViiV.